Paxlovid is still a highly effective treatment for most people infected with SARS-CoV-2 and the drug prevents many hospitalizations and deaths from COVID.
A new Covid-19 variant, Eris has entered the scene, becoming the most prevalent strain in the U.S. However, it may not be as dangerous as the ones that came before.
Columbia University’s Professor David Ho told the Post that the Univ of Hong Kong (HKU) and Beijing’s Tsinghua University had given their blessing to the plan to build a “Pandemic Research Alliance”.
The initiative by Columbia Univ Prof D Ho and HKU Prof KY Yuen to create a global partnership to study emerging Inf Dis joined by China’s Tsinghua Univ and Doherty Inst/Univ of Melbourne in Australia.
Acclaimed US-based Columbia Univ virologist Prof D. Ho and HKU microbiologist Prof KY Yuen are teaming up to create a global alliance for conducting research in emerging infectious diseases.
